"10.1371_journal.pone.0073759","plos one","2013-09-11T00:00:00Z","Kent Bailey; Amber Kirk; Shruthi Naik; Rebecca Nace; Michael B Steele; Lukkana Suksanpaisan; Xing Li; Mark J Federspiel; Kah-Whye Peng; David Kirk; Stephen J Russell","Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America; Center for Translational Science Activities, Mayo Clinic, Rochester, Minnesota, United States of America; Consulpack, Inc., Minneapolis, Minnesota, United States of America; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: SN AK KB KWP SJR. Performed the experiments: SN AK KB DK MS LS RN. Analyzed the data: SN AK KB MS LS. Contributed reagents/materials/analysis tools: XL DK MJF. Wrote the paper: AK KB SN SJR.","In the spirit of full disclosure the authors declare the following possible conflicts of interest: David Kirk is president of Consulpack, Inc. Dr. Russell is Chief Manager and Dr. Peng is secretary and treasurer of ImaNIS Life Sciences, LLC. Dr,â€™s Peng and Naik are co-founders of Omnis Pharma (Naik, Federspiel, Russell and Peng). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Kent Bailey","KB",11,TRUE,5,7,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
